What is the main MOA of Warfarin (Coumadin)?

What is the main MOA of Warfarin (Coumadin)?

• A. Vitamin K antagonist
• B. Direct thrombin inhibitor
• C. Factor Xa inhibitor
• D. Inhibits platelet aggregation

Answer: (A)

Warfarin acts by blocking the vitamin K cycle, specifically inhibiting the vitamin K epoxide reductase complex. This prevents regeneration of reduced vitamin K, which is necessary for gamma-carboxylation of clotting factors II, VII, IX, and X (and proteins C and S). Without proper gamma-carboxylation, these factors are produced in an inactive form, leading to reduced ability to generate thrombin and form clots. This mechanism is distinct from direct thrombin inhibitors or Factor Xa inhibitors, which block enzymes in the coagulation cascade, and from antiplatelet drugs that prevent platelet clumping. Therefore, the main MOA of warfarin is vitamin K antagonism that lowers the production of functional clotting factors.

Warfarin acts by blocking the vitamin K cycle, specifically inhibiting the vitamin K epoxide reductase complex. This prevents regeneration of reduced vitamin K, which is necessary for gamma-carboxylation of clotting factors II, VII, IX, and X (and proteins C and S). Without proper gamma-carboxylation, these factors are produced in an inactive form, leading to reduced ability to generate thrombin and form clots. This mechanism is distinct from direct thrombin inhibitors or Factor Xa inhibitors, which block enzymes in the coagulation cascade, and from antiplatelet drugs that prevent platelet clumping. Therefore, the main MOA of warfarin is vitamin K antagonism that lowers the production of functional clotting factors.